RAD51 and non-small cell lung carcinoma: In line with our hypothesis, 3MA, which restored the expression of RAD51 in (−)-Guaiol treated NSCLC cells, significantly inhibited the elevation of DSBs, which eventually activate cell apoptosis to eliminate dead cells [4].